Re-link HCV in Substance-Use Telemedicine Program

RecruitingOBSERVATIONAL
Enrollment

5,000

Participants

Timeline

Start Date

March 12, 2024

Primary Completion Date

August 31, 2024

Study Completion Date

December 31, 2024

Conditions
Hepatitis C
Interventions
BEHAVIORAL

Re-Link

The HCV nurse will attempt to contact the PWDU HCV via phone call and text. If unable to connect with a client via phone, an alert is added to the client's chart in the electronic medical record. When the client presents to the CBSUTP for their regular substance use follow up appointment, the chart alert is flagged by the administrative team and the client is connected with the HCV nurse via telemedicine. Clients who are connected to the HCV team are considered re-linked. The HCV nurse will provide an HCV intake as per program guidelines. Clients who would prefer to pursue treatment elsewhere will be supported with a referral to their family doctor or an alternative HCV program in the community. Clients who choose to be treated at the CBSUTP will receive a HCV consultation, DAA treatment and follow-up from the HCV clinical team onsite as per existing program guidelines.

Trial Locations (1)

M5B 2A5

RECRUITING

trueNorth Medical Centre, Toronto

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Gilead Sciences

INDUSTRY

lead

trueNorth Medical Centres

OTHER